Results 11 to 20 of about 194,150 (247)

Transcriptome analysis of endometrial tissues following GnRH agonist treatment in a mouse adenomyosis model [PDF]

Drug Design, Development and Therapy, 2017
Song Guo,1,* Xiaowei Lu,1,* Ruihuan Gu,2 Di Zhang,3 Yijuan Sun,2 Yun Feng1 1Department of Obstetrics and Gynecology, Reproductive Medicine Center, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, People’s ...
Guo S, Lu X, Gu R, Zhang D, Sun Y, Feng Y   +5 more
doaj   +2 more sources

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran [PDF]

Iranian Journal of Reproductive Medicine, 2011
Background: General concern is that the pregnancy rate is higher with GnRH-agonist as a protocol of pituitary suppression. GnRH-antagonist protocol provides a shorter period of administration and an easy flexible protocol.Objective: In this study, the ...
Ensieh Tehraninejad, Akram Ghahghaei Nezamabadi   +1 more
doaj   +1 more source

GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity

Drug Design, Development and Therapy, 2018
Song Guo,1 Zhichao Li,2 Li Yan,1 Yijuan Sun,2 Yun Feng3 1Department of Gynaecology and Obstetrics, Qianfoshan Hospital, Shandong University, Jinan, China; 2Gynecology, Shanghai Ji Ai Genetics & In Vitro Fertilization Institute, Obstetrics and ...
Guo S, Li Z, Yan L, Sun Y, Feng Y
doaj   +1 more source

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients

International Journal of Endocrinology, 2015
The reports on how to stimulate the ovaries for oocyte retrieval in good prognosis patients are contradictory and often favor one type of controlled ovarian hyperstimulation (COH).
Martin Stimpfel, Eda Vrtacnik-Bokal, Barbara Pozlep, Irma Virant-Klun   +3 more
doaj   +2 more sources

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist [PDF]

Endocrinology and Metabolism, 2013
Gonadotropin-releasing hormone (GnRH) agonist has been used in the treatment of a wide variety of sex-hormone-related diseases, as the administration of GnRH agonist can alter the secretion of gonadotropin and sex hormones.
Eun Jin Han, Ha Do Song, Ji Hoon Yang, So Young Park, Sung Hoon Kim, Hyun Koo Yoon, Chang Hoon Yim   +6 more
doaj   +1 more source

Pregnancy outcomes in PCOS patients undergoing IVF with long GnRH agonist protocol versus flexible GnRH antagonist [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2018
Introduction: IVF is a good option for Polycystic ovary syndrome patients who not respond to ovulation induction treatment. This study was performed with aim to compare pregnancy outcomes in PCOS patients undergoing IVF with long GnRH agonist versus ...
Nayereh Khadem Ghaebi, Maliheh Amirian, Seyede Houra Mousavi Vahed, Yalda Arian, Vida Vakili, Yousef Yousefi, Seyedeh Azam Tashkori Hashemi   +6 more
doaj   +1 more source

GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines [PDF]

, 2011
Breakthrough Breast CancerBackground: Gonadotrophin releasing hormone (GnRH) analogs lower estrogen levels in pre-menopausal breast cancer patients. GnRH receptor (GnRH-R) activation also directly inhibits the growth of certain cells.
Sims Andrew H, Faratian Dana, Miller, Nicola, Sims, Andrew H., Morgan, Kevin, Miller Nicola, Millar, Robert P., Langdon, Simon P., Ilgin Cagnan, Sims, Andrew, Dana Faratian, Robert P Millar, Meyer, Colette, Simon P Langdon, Colette Meyer, Harrison David J, Cagnan, Ilgin, Nicola Miller, Morgan Kevin, Millar Robert P, David J Harrison, Faratian, Dana, Langdon Simon P, Kevin Morgan, Meyer Colette, Cagnan Ilgin, Andrew H Sims, Harrison, David J., Harrison, David J.; id_orcid   +28 more
core   +2 more sources

Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas

Taiwanese Journal of Obstetrics & Gynecology, 2009
Objective: To determine the acceptability and effectiveness of a gonadotropin-releasing hormone (GnRH) agonist for the treatment of perimenopausal women with symptomatic uterine myomas.
Peng-Hui Wang, Wen-Ling Lee, Ming-Huei Cheng, Ming-Shyen Yen, Kuan-Chong Chao, Hsiang-Tai Chao   +5 more
doaj   +1 more source

Clinical pregnancy following GnRH agonist administration in the luteal phase of fresh or frozen assisted reproductive technology (ART) cycles: Systematic review and meta-analysis

European Journal of Obstetrics & Gynecology and Reproductive Biology: X, 2019
Objective(s): To study if the GnRH agonist administration in luteal phase improves clinical pregnancy rate of fresh and frozen embryo transfer. Also, this meta-analysis compares the treatment effect of luteal GnRH agonist administration between long ...
Le Thi Minh Chau, Duong Khue Tu, Philippe Lehert, Do Van Dung, Le Quang Thanh, Vo Minh Tuan   +5 more
doaj   +1 more source

Flexible Multi-dose GnRH Antagonist versus Long GnRH Agonist Protocol in Poor Responders: A Randomized Controlled Trial [PDF]

International Journal of Fertility and Sterility, 2009
Background To compare a flexible, multi-dose GnRH antagonist protocol with a long GnRH .agonist protocol in poor respo Materials and methods A randomized clinical trial of 70 poor responder patients (35 patients in GnRH antagonist protocol and 35 ...
Ensieh Shahrokh Tehraninejad, Azadeh Fazel, Arash Samiei, Batool Rashidi, Kiandokht Kiani   +4 more
doaj   +1 more source